Innovid (CTV)
(Delayed Data from NYSE)
$2.01 USD
-0.02 (-0.99%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.02 +0.01 (0.50%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth NA Momentum NA VGM
Balance Sheet
Fiscal Year End for Innovid Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 50 | 48 | 157 | 0 | 0 |
Receivables | 46 | 44 | 35 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5 | 3 | 3 | 0 | 0 |
Total Current Assets | 102 | 94 | 195 | 0 | 0 |
Net Property & Equipment | 18 | 14 | 5 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 127 | 147 | 5 | 0 | 0 |
Deposits & Other Assets | 2 | 2 | 1 | 0 | 0 |
Total Assets | 250 | 260 | 206 | 0 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 3 | 5 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 6 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 21 | 16 | 11 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 26 | 21 | 22 | 0 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 20 | 20 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8 | 11 | 22 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 54 | 54 | 44 | 0 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 379 | 357 | 294 | 0 | 0 |
Retained Earnings | -183 | -151 | -132 | 0 | 0 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 196 | 206 | 161 | 0 | 0 |
Total Liabilities & Shareholder's Equity | 250 | 260 | 206 | 0 | 0 |
Total Common Equity | 196 | 206 | 161 | 0 | 0 |
Shares Outstanding | 141.10 | 133.80 | 119.00 | 6.30 | NA |
Book Value Per Share | 1.39 | 1.54 | 1.36 | 0.00 | 0.00 |
Fiscal Year End for Innovid Corp falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 50 | 48 | 43 | 45 |
Receivables | NA | 46 | 44 | 43 | 40 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 5 | 4 | 4 | 6 |
Total Current Assets | NA | 102 | 95 | 91 | 91 |
Net Property & Equipment | NA | 18 | 18 | 19 | 17 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 127 | 129 | 130 | 146 |
Deposits & Other Assets | NA | 2 | 1 | 1 | 1 |
Total Assets | NA | 250 | 245 | 243 | 257 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 3 | 3 | 4 | 5 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 21 | 17 | 16 | 17 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 26 | 22 | 22 | 24 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 20 | 20 | 20 | 20 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 10 | 10 | 10 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 54 | 52 | 54 | 55 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 379 | 374 | 368 | 362 |
Retained Earnings | NA | -183 | -181 | -178 | -159 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 196 | 193 | 190 | 203 |
Total Liabilities & Shareholder's Equity | NA | 250 | 245 | 243 | 257 |
Total Common Equity | 0 | 196 | 193 | 190 | 203 |
Shares Outstanding | 141.80 | 141.10 | 140.10 | 138.70 | 136.60 |
Book Value Per Share | 0.00 | 1.39 | 1.38 | 1.37 | 1.48 |